Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

P Tau

Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease

Analysis of specific biomarkers in a cerebrospinal fluid sample can differentiate patients with Alzheimer’s disease from those with other types of dementia. The method, which is being studied by researchers at Sahlgrenska Academy, may eventually permit earlier detection of Alzheimer’s disease.

Due to the similarity of the symptoms, differentiating patients with Alzheimer’s from those… Biomarkers in cerebrospinal fluid can identify patients with Alzheimer’s disease   



Going Home (A short film on Dementia)

alzheimer's experience1 - ad diagnosing1 - pseudogeneral paralysis1 - treatment for huntingtons disease1 - arteriosclerosis2 - poor judgment2 - induced pluripotent stem cells1 - health and wellness1 - alzheimer's-like tau tangles1 - angina1 - risk for alzheimer's1 - apraxia3 - adam10 enzyme1 - functional activation studies1 - hospice2 - memory skills1 - decline of memory1 - senility1 - mini-strokes2 - confabulatory euphoria1 - wernicke encephalopathy2 - risk of alzheimer's3 - ophthalmoplegia4 - alzheimer's & dementia1 - cognitive function9 - ucla1 - selective serotonin reuptake inhibitor2 - ad prognosis1 - bonfiglio1 - cognitive functions1 -